Pershing Edward
Transaction: 06/30/2026
BUY
Change
+45,860
Price
Not reported
Filing
07/02/2026
Type
BUY
Provectus Biopharmaceuticals, Inc.
PVCT • Biotechnology
$0.06
▲ +0.00 (+3.90%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$24.38M
Growth
-11.2%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.08Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:33 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.06
Change3.90%
Shares Out420.28M
Market Cap$24.38M
Enterprise Value$27.96M
52W Range0.04 - 0.09
Beta0.87
P/E-5.13
P/B-3.88
P/FCF-10.05
EV/EBITDA-8.49
EV/FCF-11.53
Price$0.06
Change3.90%
Shares Out420.28M
Market Cap$24.38M
Enterprise Value$27.96M
52W Range0.04 - 0.09
Beta0.87
P/E-5.13
P/B-3.88
P/FCF-10.05
EV/EBITDA-8.49
EV/FCF-11.53
Earnings Yield-19.48%
FCF Yield-9.95%
Dividend Yield0.00%
Gross Margin99.45%
Oper. Margin-14.41%
Profit Margin-16.16%
Debt/Eq-0.47
Current Ratio0.08
Quick Ratio0.08
Revenue 5Y-11.15%
Volume199.91K
Avg Volume178.64K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
22
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak liquidity · 0.08Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Bailey Webster
Transaction: 06/30/2026
BUY
Change
+48,917
Price
Not reported
Filing
06/30/2026
Type
BUY
Lacey John III
Transaction: 06/30/2026
BUY
Change
+48,917
Price
Not reported
Filing
06/30/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Pershing Edward | BUY | +45,860 | Not reported | 06/30/2026 | 07/02/2026 |
| Bailey Webster | BUY | +48,917 | Not reported | 06/30/2026 | 06/30/2026 |
| Lacey John III | BUY | +48,917 | Not reported | 06/30/2026 | 06/30/2026 |
| Rodrigues Dominic | BUY | +45,860 | Not reported | 06/30/2026 | 06/30/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 06/05/2026 | 06/05/2026 |
| Pershing Edward | BUY | +9,436 | Not reported | 06/05/2026 | 06/05/2026 |
| Pershing Edward | BUY | 0 | $2.86 | 05/28/2026 | 05/29/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 05/23/2026 | 05/26/2026 |
| Pershing Edward | BUY | +32,089 | Not reported | 05/23/2026 | 05/26/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 05/15/2026 | 05/15/2026 |
| Pershing Edward | BUY | +22,651 | Not reported | 05/15/2026 | 05/15/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 05/07/2026 | 05/07/2026 |
| Pershing Edward | BUY | +18,876 | Not reported | 05/07/2026 | 05/07/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 04/29/2026 | 04/29/2026 |
| Pershing Edward | BUY | +30,202 | Not reported | 04/29/2026 | 04/29/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 04/04/2026 | 04/06/2026 |
| Pershing Edward | BUY | +33,977 | Not reported | 04/04/2026 | 04/06/2026 |
| Pershing Edward | BUY | 0 | $2.86 | 03/25/2026 | 03/26/2026 |
| Pershing Edward | SELL | 0 | $2.86 | 03/20/2026 | 03/20/2026 |
| Pershing Edward | BUY | +49,067 | Not reported | 03/20/2026 | 03/20/2026 |